TABLE 1.
Treatment | n | MAP |
HR |
||
---|---|---|---|---|---|
Before | After | Before | After | ||
Vehicle + vehicle | 6 | 115.0 ± 6.0 | 113.3 ± 5.0 | 395 ± 12 | 400 ± 12 |
Vehicle + 7.5 μg WIN55,212-2 | 6 | 111.3 ± 3.0 | 108.0 ± 5.0 | 375 ± 10 | 350 ± 11 |
Vehicle + 15 μg WIN55,212-2 | 8 | 113.3 ± 5.0 | 115.0 ± 3.0 | 370 ± 10 | 368 ± 17 |
Wortmannin + vehicle | 5 | 112.0 ± 6.0 | 117.0 ± 6.0 | 356 ± 15 | 376 ± 15 |
Wortmannin + 7.5 μg WIN55,212-2 | 8 | 112.0 ± 6.0 | 111.0 ± 5.0 | 360 ± 11 | 380 ± 10 |
Wortmannin + 15 μg WIN55,212-2 | 8 | 111.3 ± 3.0 | 112.0 ± 3.0 | 375 ± 10 | 363 ± 13 |
PD98059 + vehicle | 5 | 113.0 ± 4.0 | 110.0 ± 4.0 | 398 ± 16 | 390 ± 20 |
PD98059 + 15 μg WIN55,212-2 | 8 | 117.0 ± 6.0 | 115.0 ± 4.0 | 400 ± 12 | 410 ± 12 |